Year |
Citation |
Score |
2009 |
Lee PJ, Bhonsle JB, Gaona HW, Huddler DP, Heady TN, Kreishman-Deitrick M, Bhattacharjee A, McCalmont WF, Gerena L, Lopez-Sanchez M, Roncal NE, Hudson TH, Johnson JD, Prigge ST, Waters NC. Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents. Journal of Medicinal Chemistry. 52: 952-63. PMID 19191586 DOI: 10.1021/jm8008103 |
0.669 |
|
2006 |
Dow GS, Heady TN, Bhattacharjee AK, Caridha D, Gerena L, Gettayacamin M, Lanteri CA, Obaldia N, Roncal N, Shearer T, Smith PL, Tungtaeng A, Wolf L, Cabezas M, Yourick D, et al. Utility of alkylaminoquinolinyl methanols as new antimalarial drugs. Antimicrobial Agents and Chemotherapy. 50: 4132-43. PMID 16966402 DOI: 10.1128/Aac.00631-06 |
0.622 |
|
2005 |
McCalmont WF, Patterson JR, Lindenmuth MA, Heady TN, Haverstick DM, Gray LS, Macdonald TL. Investigation into the structure-activity relationship of novel concentration dependent, dual action T-type calcium channel agonists/antagonists. Bioorganic & Medicinal Chemistry. 13: 3821-39. PMID 15863008 DOI: 10.1016/J.Bmc.2005.03.004 |
0.675 |
|
2005 |
Gray L, Perez-Reyes E, Gomora J, Haverstick D, Shattock M, McLatchie L, Harper J, Brooks G, Heady T, Macdonald T. Erratum to “The role of voltage gated T-type Ca2+ channel isoforms in mediating “capacitative” Ca2+ entry in cancer cells” [Cell Calcium 36 (2004) 489–497] Cell Calcium. 37: 603. DOI: 10.1016/J.Ceca.2004.11.002 |
0.576 |
|
2004 |
Gray LS, Perez-Reyes E, Gomora JC, Gamorra JC, Haverstick DM, Shattock M, McLatchie L, Harper J, Brooks G, Heady T, Macdonald TL. The role of voltage gated T-type Ca2+ channel isoforms in mediating "capacitative" Ca2+ entry in cancer cells. Cell Calcium. 36: 489-97. PMID 15488598 DOI: 10.1016/J.Ceca.2004.05.001 |
0.589 |
|
2004 |
McCalmont WF, Heady TN, Patterson JR, Lindenmuth MA, Haverstick DM, Gray LS, Macdonald TL. Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 14: 3691-5. PMID 15203145 DOI: 10.1016/J.Bmcl.2004.05.011 |
0.674 |
|
2003 |
Smith KS, Smith PL, Heady TN, Trugman JM, Harman WD, Macdonald TL. In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity. Chemical Research in Toxicology. 16: 123-8. PMID 12588182 DOI: 10.1021/Tx025569N |
0.627 |
|
2001 |
Heady TN, Gomora JC, Macdonald TL, Perez-Reyes E. Molecular pharmacology of T-type Ca2+ channels. Japanese Journal of Pharmacology. 85: 339-50. PMID 11388636 DOI: 10.1254/Jjp.85.339 |
0.654 |
|
2000 |
Haverstick DM, Heady TN, Macdonald TL, Gray LS. Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. Cancer Research. 60: 1002-8. PMID 10706116 |
0.524 |
|
Show low-probability matches. |